Geneva – Today, the Medicines Patent Pool (MPP) welcomed Prof. Mojisola Christianah Adeyeye and Prof. John-Arne Røttingen as its newest Board members.

“We are absolutely delighted to have Prof. Adeyeye and Prof. Røttingen joining the MPP Governance Board,” said Dr Marie-Paule Kieny, Chair of the MPP Board. “With their outstanding experience in global health and expertise in issues that are right at the heart of MPP’s work – from regulatory affairs, to complex global health challenges including COVID-19, intellectual property (IP) and research and development (R&D) – they will be tremendous assets for our Board”.

Prof. Mojisola Christianah Adeyeye is currently the Director General of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) and serves as the Chair of the Steering Committee of the African Medicines Regulatory Harmonization (AMRH) and the World Health Organzation (WHO)-based Global Paediatric Regulatory Network. She represents NAFDAC on the International Coalition of Medicines Regulatory Authorities (ICMRA) and has been invited to be on the WHO Regional Expert Advisory Committee on Traditional Medicine for COVID-19. Prof. Adeyeye brings to the MPP Board her strong expertise in R&D, regulatory affairs, product development, IP, vaccines, HIV, paediatrics and longstanding experience working in low- and middle-income countries, especially in Africa. Among other accolades, Prof. Adeyeye has received the recognition of being the First African Woman Fellow in the American Association of Pharmaceutical Scientists (AAPS). She holds a PhD in Pharmaceutics from the University of Georgia, USA. (read full bio)

Prof. John-Arne Røttingen is the newly appointed Ambassador for Global Health at the Ministry of Foreign Affairs, Norway. He is Visiting Fellow of Practice at Blavatnik School of Government, Oxford University, and was the founding Chief Executive Officer of CEPI – Coalition for Epidemic Preparedness Innovations. He has held many distinguished positions including Chief Executive of the Research Council of Norway; Executive Director of Infection Control and Environmental Health at the Norwegian Institute of Public Health; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo; and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health. He holds an MD PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University. Prof. Røttingen’s wealth of knowledge and expertise in global health research and innovation, health policy, international development and epidemiology will be extremely valuable for furthering MPP’s commitment of leaving no one behind. (read full bio)

Read more about the work of MPP’s Governance Board:

Governance Board